This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The vaccine, the brainchild of Dr. Louis Picker and Dr. Klaus Frueh, has been two decades in the making as the scientists have toiled to come up with a drug to fight the tricky virus.
As the scientific community scrambles to find a drug that can effectively treat tens of thousands of patients sickened by a new respiratory virus, they are trying some surprising remedies: medicines targeting known killers like HIV, Ebola and malaria.
The Trump administration Tuesday unveiled a plan to distribute HIV prevention medication free to individuals who do not have prescription drug insurance coverage.
Researchers at Oregon Health & Science University announced an initial breakthrough on a vaccine against malaria, which killed nearly 500,000 people worldwide in 2017.
Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections.
The Senate unanimously passed a bill Wednesday designed to protect corrections officers from exposure to HIV or Hepatitis C, but discussion around the bill may have sensationalized the risk of acquiring these diseases.
Sen. Bill Hansell, R-Pendleton, has introduced two bills that are designed to improve public policy at the intersection of healthcare and corrections, allowing the physicians of prison guards to get information about HIV exposure and closing a loophole to require health insurers to cover medical costs for juveniles held on bail.
Oregonians have a 1 in 200 chance of being diagnosed with HIV, according to the CDC.
But the Oregon Health Authority thinks that by focusing on three key strategies, all new infections can be stopped by 2021.